SCHEMBL7671191

SCHEMBL7671191

CCCCn1cnc2c(OC)nc(Nc3ccccc3OC)nc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GBA1 P04062 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.44
▸ MAPT P10636 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ PDGFRA P16234 3/20 0.43
▸ CCNE1 P24864 3/20 0.43
▸ CDK2 P24941 3/20 0.43
▸ EGFR P00533 1/20 0.42
▸ CTSL P07711 4/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ YTHDC1 Q96MU7 1/20 0.41
▸ TMIGD3 P0DMS9 2/20 0.40
▸ ADORA2A P29274 2/20 0.40
▸ ADORA1 P30542 2/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.40
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7672318 0.94 PDE1A (0.43) GBA1ALDH1A1KDM4ESMN1; SMN2PDGFRA
SCHEMBL7675152 0.89 PDGFRA (0.43) PDGFRACCNE1CDK2CTSLTMIGD3
SCHEMBL7666120 0.88 PDGFRA (0.49) ALDH1A1MAPTSMN1; SMN2PDGFRACCNE1
SCHEMBL7661515 0.87 CCNE1 (0.54) PDGFRACCNE1CDK2CTSLTMIGD3
SCHEMBL7666144 0.83 CDK4 (0.45) ALDH1A1MAPTKDM4EKMT2APDGFRA
SCHEMBL7672171 0.83 SHMT2 (0.46) MAPTSMN1; SMN2PDGFRACCNE1CDK2
SCHEMBL7358873 0.83 CTSL (0.46) PDGFRACCNE1CDK2CTSL
SCHEMBL7672863 0.83 PDGFRA (0.52) PDGFRACCNE1CDK2TMIGD3ADORA2A
SCHEMBL7672785 0.82 PDGFRA (0.48) ALDH1A1MAPTSMN1; SMN2PDGFRACCNE1
SCHEMBL7674300 0.81 CTSL (0.50) PDGFRACCNE1CDK2CTSLNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US claimed
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 — — US disclosed
Send feedback